Clinical Trials Begin for a Possible Spinocerebellar Ataxia Treatment
According to a story from pharmavoice.com, the pharmaceutical company Cadent Therapeutics has announced the beginning of the Phase I clinical study for its drug candidate CAD-1883. The therapy is a…